Literature DB >> 20051785

Withdrawal from multiple sedative agent therapy in an infant: is dexmedetomidine the cause or the cure?

Cindy Darnell1, Jeff Steiner, Peter Szmuk, Paul Sheeran.   

Abstract

OBJECTIVE: To report withdrawal symptoms experienced by an infant following the prolonged use of dexmedetomidine.
DESIGN: Case report.
SETTING: Pediatric intensive care unit at a freestanding tertiary care children's hospital. PATIENTS: One pediatric patient with respiratory failure following pertussis infection that required prolonged intubation and sedation. The patient required dexmedetomidine to maintain optimal sedation before ventilator weaning. Subsequent to receiving dexmedetomidine the patient developed withdrawal symptoms.
CONCLUSION: In patients who fail to achieve adequate sedation with the use of traditional medications, dexmedetomidine is an adequate alternative. However, abrupt discontinuation of dexmedetomidine may result in withdrawal symptoms that may be avoided with a dexmedetomidine taper.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20051785     DOI: 10.1097/PCC.0b013e3181a66131

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  11 in total

1.  Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.

Authors:  Nelson H Burbano; Andrea V Otero; Donald E Berry; Richard A Orr; Ricardo A Munoz
Journal:  Intensive Care Med       Date:  2011-12-13       Impact factor: 17.440

2.  Dexmedetomidine: Are There Going to be Issues with Prolonged Administration?

Authors:  Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2010-01

3.  Effects of Clonidine on Withdrawal From Long-term Dexmedetomidine in the Pediatric Patient.

Authors:  Allison B Lardieri; Nicholas M Fusco; Shari Simone; L Kyle Walker; Jill A Morgan; Kristine A Parbuoni
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jan-Feb

4.  Prolonged Dexmedetomidine Infusion and Drug Withdrawal In Critically Ill Children.

Authors:  Astrid S Haenecour; Winnie Seto; Charline M Urbain; Derek Stephens; Peter C Laussen; Corrine R Balit
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Nov-Dec

5.  Sedation, sleep promotion, and delirium screening practices in the care of mechanically ventilated children: a wake-up call for the pediatric critical care community*.

Authors:  Sapna R Kudchadkar; Myron Yaster; Naresh M Punjabi
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

6.  Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease.

Authors:  Francis Lam; Adnan T Bhutta; Joseph D Tobias; Jeffrey M Gossett; Laura Morales; Punkaj Gupta
Journal:  Pediatr Cardiol       Date:  2012-02-11       Impact factor: 1.655

7.  Dexmedetomidine Use in Critically Ill Children With Acute Respiratory Failure.

Authors:  Mary Jo C Grant; James B Schneider; Lisa A Asaro; Brenda L Dodson; Brent A Hall; Shari L Simone; Allison S Cowl; Michele M Munkwitz; David Wypij; Martha A Q Curley
Journal:  Pediatr Crit Care Med       Date:  2016-12       Impact factor: 3.624

8.  Optimizing Sedation Management to Promote Early Mobilization for Critically Ill Children.

Authors:  Mary Saliski; Sapna R Kudchadkar
Journal:  J Pediatr Intensive Care       Date:  2015-09-01

9.  Safety and Effectiveness of Dexmedetomidine in the Pediatric Intensive Care Unit (SAD-PICU).

Authors:  Laura Carney; Jennifer Kendrick; Roxane Carr
Journal:  Can J Hosp Pharm       Date:  2013-01

10.  Incidence of Dexmedetomidine Withdrawal in Adult Critically Ill Patients: A Pilot Study.

Authors:  Rima H Bouajram; Krupa Bhatt; Rhiannon Croci; Laura Baumgartner; Kathleen Puntillo; James Ramsay; Ashley Thompson
Journal:  Crit Care Explor       Date:  2019-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.